Seizure: European Journal of Epilepsy
Volume 19, Issue 3 , Pages 190-194 , April 2010

Unusual consequences of status epilepticus in Dravet syndrome

  • M. Chipaux

      Affiliations

    • Service de neuropédiatrie, Centre de référence épilepsies rares, AP-HP, Hôpital Necker Enfants Malades, Paris, France
    • Inserm, U663, Paris, F-75015 France; University Paris Descartes, Paris, F-75015, France
    • Corresponding Author InformationCorresponding author at: Service de neuropédiatrie, Centre de référence épilepsies rares, AP-HP, Hôpital Necker Enfants Malades, Paris, France. Tel.: +33 144481536; fax: +33 142192692.
    • ,
  • N. Villeneuve

      Affiliations

    • Centre Saint-Paul, Hôpital Henri Gastaut, Marseille, France
    • ,
  • P. Sabouraud

      Affiliations

    • Hôpital Américain, Service de Pédiatrie A, CHU de Reims, Reims, France
    • ,
  • I. Desguerre

      Affiliations

    • Service de neuropédiatrie, Centre de référence épilepsies rares, AP-HP, Hôpital Necker Enfants Malades, Paris, France
    • ,
  • N. Boddaert

      Affiliations

    • Service de radiologie pédiatrique, AP-HP, Hôpital Necker Enfants Malades, Paris, France
    • ,
  • C. Depienne

      Affiliations

    • UF de neurogénétique moléculaire et cellulaire, Hôpital Pitié-Salpétrière, Paris, France
    • ,
  • C. Chiron

      Affiliations

    • Service de neuropédiatrie, Centre de référence épilepsies rares, AP-HP, Hôpital Necker Enfants Malades, Paris, France
    • Inserm, U663, Paris, F-75015 France; University Paris Descartes, Paris, F-75015, France
    • ,
  • O. Dulac

      Affiliations

    • Service de neuropédiatrie, Centre de référence épilepsies rares, AP-HP, Hôpital Necker Enfants Malades, Paris, France
    • Inserm, U663, Paris, F-75015 France; University Paris Descartes, Paris, F-75015, France
    • ,
  • R. Nabbout

      Affiliations

    • Service de neuropédiatrie, Centre de référence épilepsies rares, AP-HP, Hôpital Necker Enfants Malades, Paris, France
    • Inserm, U663, Paris, F-75015 France; University Paris Descartes, Paris, F-75015, France

Received 30 June 2009 ,Revised 7 January 2010 ,Accepted 15 January 2010.

References 

  1. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy (Dravet syndrome). In:  Roger J,  Bureau M, Dravet Ch ,  Genton P,  Tassinari CA,  Wolf P editor. Epileptic Syndromes in Infancy, Childhood and Adolescence. 3rd ed.. London: John Libbey; 2002;p. 81–103
  2. Oguni H, Hayashi K, Awaya Y, Fukuyama Y, et Osawa M. Severe myoclonic epilepsy in infants–a review based on the Tokyo Women's Medical University series of 84 cases. Brain Dev. 2001;23(November (7)):736–748
  3. Dravet C, Bureau M, Oguni H, Fukuyama Y, Cokar O. Severe myoclonic epilepsy in infancy: Dravet syndrome in Delgado. In:  Escueta AV,  Guerrini R,  Medina MT,  Genton P,  Bureau M,  Dravet C editor. Advances in Neurology. vol. 95:Philadelphia: Lippincott Williams and Wilkins; 2005;p. 71–102
  4. Siegler Z, Barsi P, Neuwirth M, Jerney J, Kassav M, Jansky J, et al. Hippocampal sclerosis in severe myoclonic Epilepsy in Infancy: a retrospective MTI Study. Epilepsia. 2005;45556(5):704–708
  5. Striano P, Mancardi MM, Biancheri R, Madia F, Gennaro E, Paravidino R, et al. Brain MRI findings in severe myoclonic epilepsy in infancy and genotype-phenotype correlations. Epilepsia. 2007;48(June (6)):1092–1096
  6. Fountain N. Status epilepticus: risk factors and complications. Epilepsia. 2000;Suppl. 2:S23–30
  7. Novorol CL, Chin RF, Scott RC. Outcome of convulsive status epilepticus: a review. Arch Dis Child. 2007 Nov;92(11):948–951
  8. Wiest R, Von Bredow F, Schindler K, Schauble B, Slotboom J, Brekenfeld C, et al. Detection of regional blood perfusion changes in epileptic seizures with dynamic brain perfusion CT—a pilot study. Epilepsy Res. 2006;72(December (2–3)):102–110
  9. Coulter DA, DeLorenzo RJ. Basic mechanisms of status epilepticus. Advances in Neurology. vol. 79. Philadelphia: Lippincott Williams and Wilkins; 1999;pp. 725–733
  10. Nabbout R. Can SCN1A mutations account for SUDEP?. Epilepsia. 2008;49(February (2)):367–368
  11. Hindocha N, Nashef L, Elmslie F, Birch R, Zuberi S, Al-Chalabi A, et al. Makoff A Two cases of sudden unexpected death in epilepsy in a GEFS+ family with an SCN1A mutation. Epilepsia. 2008;49(February (2)):360–365
  12. Chiron C, Marchand MC, Tran A, Rey E, d’Athis P, Vincent J, et al. Stiripentol in severe myoclonic epilepsy in infancy: a randomised placebo-controlled syndrome-dedicated trial. STICLO study group. Lancet. 2000;356(November (9242)):1638–1642
  13. Wada DR, Harashima H, Ebling W, Osaki EW, Stanski DR. Effects of thiopental on regional blood flows in the rat. Anesthesiology. 1996;84(March (3)):596–604
  14. de Bray JM, Granry JC, Monrigal JP, Leftheriotis G, et Saumet JL. Effects of thiopental on middle cerebral artery blood velocities: a transcranial Doppler study in children. Childs Nerv Syst. 1993;9(July (4)):220–223
  15. Van Gestel JP, Blussé , van Oud-Alblas HJ, Malingré M, Versvers FF, Braun KP, et al. Propofol and thiopental for refractory status epilepticus in children. Neurology. 2005;65(August (4)):591–592
  16. Tanabe T, Awaya Y, Matsuishi T, Iyoda K, Nagai T, Kurihara M, et al. Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy–a nationwide questionnaire survey in Japan. Brain Dev. 2008;30:629–635

PII: S1059-1311(10)00008-7

doi: 10.1016/j.seizure.2010.01.007

Seizure: European Journal of Epilepsy
Volume 19, Issue 3 , Pages 190-194 , April 2010

Article Tools

* Image Usage & Resolution